SEC Form 4 · accession 0001127602-15-000617
CUBIST PHARMACEUTICALS INC · CBST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick V.J.J. Vink
Officer — EVP and COO
Period of report
Jan 1, 2015
Accepted (ET)
Jan 5, 2015 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000912183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 5,496 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Jan 1, 2015 | A | 7,451 | A | Jan 1, 2016 | Jan 1, 2025 | Common Stock | 7,451 | 14,902 | D |
Explanation of responses
- F1Granted in connection with promotion to Executive Vice President and Chief Operating Officer on January 1, 2015.
- F2Option vests 6.25% quarterly over a four-year period.